RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS

by D. A. Anichkov, N. A. Shostak
Published 2015-12-01

EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)

by I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko
Published 2016-01-01

SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS

by S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova
Published 2016-01-01

Rasprostranennost' ozhireniya,kardiometabolicheskikh faktorov riska,metabolicheskogo sindroma i sakharnogo diabetasredi zhenshchin razlichnykh vozrastnykh gruppMoskovskogo regiona

Published 2009-12-01

АЛГОРИТМ СТРАТИФИКАЦИИ СЕРДЕЧНО-СОСУДИСТОГО РИСКА У МУЖЧИН В ВОЗРАСТЕ 18-29 ЛЕТ С СИНДРОМОМ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ...

by A. N. Zayats, V. I. Shyshko
Published 2021-05-01

CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE

by M. I. Shupina, O. Ju. Korennova, E. N. Loginova
Published 2015-09-01

VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT

by R. G. Oganov
Published 2015-09-01

REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIO...

by M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova
Published 2015-12-01

CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE

by A. V. Kontsevaya, A. M. Kalinina, Yu. M. Pozdnyakov, S. V. Belonosova, M. B. Khudyakov
Published 2016-01-01

CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS

by D. A. Anichkov, A. A. Platonova
Published 2016-01-01

ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES

by Y. A. Karpov
Published 2015-12-01

ДИСЛИПИДЕМИИ: ОБЗОР РЕКОМЕНДАЦИЙ ESC/EAS 2019 ПО ДИАГНОСТИКЕ И ЛЕЧЕНИЮ. ЧАСТЬ 2 – ТАРГЕТНАЯ ТЕРАПИЯ

by V. M. Pyrochkin, Y. I. Karpovich, E. V. Mironchik, A. V. Kovtun
Published 2021-05-01

Total glucose control: the role of post-prandial glucose

by PAUL S JELLINGER
Published 2004-06-01

Cardiovascular risk factors and diabetic foot syndrome in south indian diabetic population

by M M Rennis, E K Shavarova, Zh D Kobalava
Published 2011-06-01

Alogliptin – the new member of DPP-4 inhibitors class

by Nina Aleksandrovna Petunina, Anna Leont'evna Terekhova
Published 2014-12-01

ВЛИЯНИЕ ОБРАЗОВАТЕЛЬНОГО СТАТУСА МУЖЧИН И ЖЕНЩИН НА РИСК ФАТАЛЬНЫХ СЕРДЕЧНО-СОСУДИСТЫХ ОСЛОЖНЕНИЙ...

by E. A. Sharlaeva, K. A. Kuznetsova, E. N. Vorobyova, A. S. Kazyzaeva
Published 2015-11-01

THE USE OF MULTI-COMPONENT THERAPY IN THE MANAGEMENT OF METABOLIC SYNDROME

by S. V. Nedogoda, I. N. Barykina, A. S. Salasyuk, V. Yu. Khripaeva, V. O. Smirnova
Published 2016-02-01

Преимущества оптимизации алгоритма терапии статинами в амбулаторной практике

Published 2021-03-01

Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii

by G Mancia, R Fagard
Published 2013-12-01

Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii

by G Mancia, R Fagard
Published 2013-09-01